Distinct patterns of expression of interleukin-1 α and β by normal and cancerous human ovarian tissues

European Cytokine Network

Volumn 8, Issue 2, 1997, Pages 179-187

  Huleihel, Mahmoud ^a   Maymon, Eli ^a   Piura, Benjamin ^a   Prinsloo, Isebrand ^a   Benharroch, Daniel ^a   Yanai Inbar, Ilana ^a   Glezerman, Marek ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cytokines; Human ovarian tissues; Immunohistochemical staining; Interleukin 1 (IL 1); Primary ovarian cell lines

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ARTICLE; BIOASSAY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY CANCER; PROTEIN EXPRESSION;

CELL LINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; KINETICS; LIPOPOLYSACCHARIDES; OVARIAN NEOPLASMS; OVARY; TUMOR CELLS, CULTURED;

EID: 0031421333     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Servo S F, Scully R E, Sobin L H. 1973. International histologic classification of ovarian tumors. 9. Geneva : WHO.
2. Rao B R, Slotman B J. 1991. Endocrine factors in common epithelial ovarian cancer. (Review) Endocr. Rev. 12: 14.
3. Adashi E Y. 1990. The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood eel series. (Review) Endocr. Rev. 11: 454.
4. Dinarello C A. 1996. Biologic basis for interleukin-1 in diseases. Blood 87: 2095.
5. Akira S, Hirano T, Taga T, Kishimoto T. 1990. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). (Review) FASEB J. 4: 2860.
6. Hurwitz A, Loukides J, Ricciarell E, Botero L, Katz E, McAllister J M, Garcia J E, Rohan R, Adashi E Y, Hernandez E R. 1992. Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J. Clin. Invest. 89: 1746.
7. Takakura K, Taii S, Fukuoka M, Yasuda K, Tagaya Y, Yodoi J, Mori T. 1989. Interleukin-2 receptor/p55(Tac)-inducing activity in porcine follicular fluids. Endocrinology 125: 618.
8. Gottschall P E, Uehara A, Hoffmann S T, Arimura A. 1987. Interleukin-1 inhibits follicle stimulating hormone-induced differentiation in rat granulosa cells in vitro. Biochem. Biophys. Res. Commun. 149: 502.
9. Fukuoka M, Yasuda K, Tau S, Takakura K, Mori T. 1989. Interleukin-1 stimulates growth and inhibits progesterone secretion in cultures of porcine granulosa cells. Endocrinology 124: 884.
10. Haskill S, Becker S, Fowler W, Walton L. 1982. Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumor and ascites material. Br. J. Cancer 45: 728.
11. Kutteh S, Baker V V, Doellgast G J. 1990. Autologous antibodies eluted from membrane fragments in human ovarian epithelial nepoplastic effusion. III. Cytotoxic potential and characteristics of antigen(s). Am. J. Obstet. Gynecol. 163: 1301.
12. Moradi M M, Carson L F, Weinberg B, Haney A F, Twiggs L B, Ramakrishnan S. 1993. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer. 72: 2433.
13. Kutteh W H, Kutteh C C. 1992. Quantification of tumor necrosis factor-α, interleukin-1β, and interleukin-6 in the effusion of ovarian epithelial neoplasm. Am. J. Obstet. Gynecol. 167: 1864.
14. Arbeit J M. 1990. Molecules, cancer, and the surgeon. A review of molecular biology and its implications for surgical oncology. (Review) Ann. Surg. 212: 3.
15. Benharroch D, Prinsloo I, Apte R N, Yermiahu T, Geffen D B, Yanai-Inbar I, Gopas J. 1996. Interleukin-1 and tumor necrosis factor-α in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features. Eur. Cytokine Netw. 7: 51.
16. Gelin J, Andersson C, Lundholm K. 1991. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res. 51: 880.
17. Tacha D E, Mckinney L. 1992. Casein reduced non-specific background staining in immunolabeling techniques. J. Histotechnol. 15: 127.
18. Gillis S, Mizel S B. 1981. T-cell lymphoma model for the analysis of interleukin-1 mediated T-cell activation. Proc. Natl. Acad. Sci. 78: 1133.
19. Gillis S M, Ferm W O, Smith K A. 1978. T-cell growth factor: parameters of production and quantitative microassay for activity. J. Immunol. 20: 2027.
20. Mosman T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55.
21. Wu S, Rodabaugh K, Martinez-Maza O, Watson J M, Silberstein D S, Boyer C M, Peters W P, Weinberg J B, Berek J S, Bast R C Jr. 1992. Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6 and tumor necrosis factor-α. Am. J. Obstet. Gynecol. 166: 997.
22. Lachman L B, Brown D C, Dinarello C A. 1987. Growth-promoting effect of recombinant interleukin-1 and tumor necrosis factor for human astrocytoma cell line. J. Immunol. 138: 2913.
23. Berkowitz R S, Hill J A, Kurtz C B, Andersen D J. 1988. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am. J. Obstet. Gynecol. 158: 199.
24. Haskill S, Martin G, van Le L, Morris J, Peace A, Bigler C F, Jaffe G J, Hammerberg C, Sporn S A, Fong S. 1991. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88: 3681.
25. Maier J A, Voulalas P, Roeder D, Maciag T. 1990. Extension of the life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249: 1570.
26. Holtmann H, Wallach D. 1987. Down regulation of the receptors for tumor necrosis factor by interleukin-1 and 4beta-phorbol-12 -myristate-13-acetate. J. Immunol. 139: 1161.
27. Ye K, Koch K C, Clark B D, Dinarello C A. 1992. Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression. Immunology 75: 427.
28. Punnonen J, Heinonen P K, Kuoppala T, Jansen C T, Punnonen R. 1991. Production of interleukin-1β and tumor necrosis factor-α in patients with benign or malignant ovarian tumors. J. Cancer Res. Clin. Oncol. 117: 587.
29. Watson J M, Sensinataffar J L, Berek J S, Martinez-Maza O. 1990. Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50: 6959.
30. Li B Y, Mohanraj D, Olson M C, Moradi M, Twiggs L, Carson L F, Ramakrishnan S. 1992. Human ovarian epithelial cancer cells cultures in vitro express both interleukin-1α and β genes. Cancer Res. 52: 2248.